Filtered By:
Condition: Stroke
Cancer: Cancer
Drug: Aspirin

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 120 results found since Jan 2013.

Well: Ask Well: Taking a Daily Aspirin
Adults ages 50 to 69 who are at high risk for heart attack or stroke should take a daily low-dose aspirin to prevent both heart attacks and strokes as well colorectal cancer.
Source: NYT - May 6, 2016 Category: American Health Authors: RONI CARYN RABIN Tags: Aspirin Colon and Colorectal Cancer Heart Stroke Ask Well Featured Live Source Type: news

Daily low-dose aspirin may help combat cancer
Conclusion The systematic review looked at 47 studies and attempted to combine the results, looking for evidence of a beneficial effect of low-dose aspirin on risk of death in people already diagnosed with cancer. The few RCTs identified – the best-quality evidence – did not provide conclusive evidence that aspirin improves survival rates. The rest of the studies were observational in nature, so cannot prove that aspirin reduces the risk of death from cancer. The only significant results were for a 24% reduction in risk of death from colon cancer, and a possible 11% reduced risk of death from prostate cancer. However,...
Source: NHS News Feed - April 22, 2016 Category: Consumer Health News Tags: Cancer Medication Source Type: news

Aspirin a day may push death away, new study says
Taking an aspirin a day might help prevent heart attacks, stroke and colon cancer.
Source: CNN.com - Health - April 12, 2016 Category: Consumer Health News Source Type: news

Daily aspirin 'protects against heart attack and colon cancer' in certain patients
The US Preventative Services Task Force recommends people aged 50 to 59 who are at risk of cardiovascular disease take a daily dose of aspirin to lower their risk of heart attack, stroke and colon cancer.
Source: the Mail online | Health - April 11, 2016 Category: Consumer Health News Source Type: news

Task Force Releases Recommendations on Aspirin to Prevent Colon Cancer, Heart Disease
By Stacy SimonRESOURCES: Aspirin and Cancer Prevention: What the Research Really Shows The United States Preventive Services Task Force (USPSTF) has published new recommendations about aspirin to help prevent cardiovascular disease (heart attacks and strokes) and colorectal cancer (commonly called colon cancer).The USPSTF says people who are ages 50-59 years, who have at least a 10% risk of developing cardiovascular disease within the next 10 years, and who have no increased risk for bleeding should take low-dose aspirin regularly to help prevent heart attack, stroke, and colon cancer. Candidates should also have a l...
Source: American Cancer Society :: News and Features - April 11, 2016 Category: Cancer & Oncology Tags: Colon/Rectum Cancer Source Type: news

Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
Conclusion: Lifetime aspirin use for primary prevention initiated at younger ages (40 to 69 years) and in persons with higher CVD risk shows the greatest potential for positive net benefit. Primary Funding Source: Agency for Healthcare Research and Quality. PMID: 27064573 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - April 11, 2016 Category: Internal Medicine Authors: Dehmer SP, Maciosek MV, Flottemesch TJ, LaFrance AB, Whitlock EP Tags: Ann Intern Med Source Type: research

Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force.
Conclusion: Consideration of the safety of primary prevention with aspirin requires an individualized assessment of aspirin's effects on bleeding risks and expected benefits because absolute bleeding risk may vary considerably by patient. Primary Funding Source: Agency for Healthcare Research and Quality. PMID: 27064261 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - April 11, 2016 Category: Internal Medicine Authors: Whitlock EP, Burda BU, Williams SB, Guirguis-Blake JM, Evans CV Tags: Ann Intern Med Source Type: research

Pop a daily aspirin to help prevent heart attacks, stroke and colon cancer, expert panel says
Taking a daily dose of aspirin can help prevent both heart disease and colorectal cancer in adults ages 50 to 69 who are at an increased risk for cardiovascular problems, an independent panel of medical experts said Monday. The final recommendation from the U.S. Preventive Services Task Force said that low-dose aspirin — typically, 81 mg […]
Source: Washington Post: To Your Health - April 11, 2016 Category: Consumer Health News Authors: Lena H. Sun Tags: health cancer Source Type: news

USPSTF publishes recommendation on taking aspirin to prevent heart attack, stroke, and colorectal cancer
(American College of Physicians) The US Preventive Services Task Force recommends that people who are 50-69 years old, have increased risk of cardiovascular disease (CVD), and who are not at increased risk for bleeding, consider taking aspirin for primary prevention of CVD and colorectal cancer. The full recommendation and evidence reviews are published in Annals of Internal Medicine.
Source: EurekAlert! - Cancer - April 11, 2016 Category: Cancer & Oncology Source Type: news

Better than Aspirin for Your Heart
If you’ve been diagnosed with heart disease, the chances are you’ve been told to take low-dose aspirin every day as a preventative measure against heart attack and stroke. It’s most commonly prescribed for patients with congestive heart failure. This is the inability of your heart to pump as much blood as your body needs. And this is a big worry to me, because there is very little evidence that aspirin helps. In fact, regular use of aspirin — even baby aspirin — can do you more harm than good. Common Aspirin Beliefs The idea is that aspirin thins the blood, making it easier to pump.  It is also s...
Source: Al Sears, MD Natural Remedies - April 1, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Heart Health Source Type: news

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome
Conclusions Neoplasm events were infrequent during long-term DAPT after ACS, were associated with differential cancer-screening practices across regions, and the frequency of neoplasm detection was similar with prasugrel vs. clopidogrel. Trial registration ClinicalTrials.gov identifier: NCT00699998.
Source: European Heart Journal - January 21, 2016 Category: Cardiology Authors: Roe, M. T., Cyr, D. D., Eckart, D., Schulte, P. J., Morse, M. A., Blackwell, K. L., Ready, N. E., Zafar, S. Y., Beaven, A. W., Strickler, J. H., Onken, J. E., Winters, K. J., Houterloot, L., Zamoryakhin, D., Wiviott, S. D., White, H. D., Prabhakaran, D., Tags: Acute coronary syndromes Source Type: research

Every Little Anniversary
One of the things they tell you after they’ve informed you that you have cancer or that you’ve had a stroke—after they tell you about the resections and the radiation—after they tell you about the aspirin and the clopidogrel—after you’re stable medically but still more than a little unstable emotionally—is to look for a support group. I had the kind of cancer that you learn about in medical school and then never see. I was decades younger than most of my physicians’ patients with stroke. The local support groups didn’t seem to fit me. I looked online at first, but then—even though I found a few people w...
Source: JAMA - December 1, 2015 Category: Journals (General) Source Type: research

A Cost-Effectiveness Analysis Of Aspirin In The Primary Prevention Of Cardiovascular Diseases And Colorectal Cancer
This study aims to assess the cost-effectiveness of aspirin in the primary prevention of cardiovascular events (myocardial infarction (MI) and ischemic stroke (IS)) and colorectal cancer (CRC) in the low-risk general population in the United States (US).
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: S Soon, WJ Chia, K Redekop, HL Wee Source Type: research

Antrodia camphorata Potentiates Neuroprotection against Cerebral Ischemia in Rats via Downregulation of iNOS/HO-1/Bax and Activated Caspase-3 and Inhibition of Hydroxyl Radical Formation.
In this study, we sought to investigate the molecular mechanisms of neuroprotective effects of A. camphorata in middle cerebral artery occlusion (MCAO) rats. A selective occlusion of the middle cerebral artery (MCA) with whole blood clots was used to induce ischemic stroke in rats and they were orally treated with A. camphorata (0.25 and 0.75 g/kg/day) alone or combined with aspirin (5 mg/kg/day). To provide insight into the functions of A. camphorata mediated neuroprotection, the expression of Bax, inducible nitric oxide synthase (iNOS), haem oxygenase-1 (HO-1), and activated caspase-3 was determined by Western blot a...
Source: Evidence-based Complementary and Alternative Medicine - September 19, 2015 Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research